• Evolus to Participate in Two Upcoming Investor Conferences

    Источник: Nasdaq GlobeNewswire / 02 мар 2021 15:05:00   America/Chicago

    NEWPORT BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in two upcoming virtual investor conferences.

    Event:H.C. Wainwright Global Life Sciences Conference
    Format:Fireside Chat & 1x1 Meetings
    Date:Tuesday, March 9, 2021
    Time:7:00am ET
    Location:  Webcast Link
      
    Event:Barclays Global Healthcare Conference
    Format: Fireside Chat & 1x1 Meetings
    Date:Wednesday, March 10, 2021
    Time:1:15pm – 1:40pm ET
    Location:Webcast Link

    Audio webcasts of Evolus’ fireside chats at the H.C. Wainwright Global Life Sciences Conference and Barclays Global Healthcare Conference will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.

    About Evolus, Inc.

    Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com.

    Jeuveau® is a registered trademark of Evolus, Inc.

    Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

    Evolus, Inc. Contacts:

    Investor Contact:
    Ashwin Agarwal, Evolus, Inc.
    Vice President, Finance, Investor Relations & Treasury
    Tel: +1-949-284-4559
    Email: IR@Evolus.com

    Media Contact:
    Crystal Muilenburg, Evolus, Inc.
    Chief Marketing Officer
    Tel: +1-949-284-4506
    Email: media@evolus.com


    Primary Logo

Опубликовать